Patent details

EP3242666 Title: COMPOUND FOR USE IN TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR

Basic Information

Publication number:
EP3242666
PCT Application Number:
US2016012289
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167009364
PCT Publication Number:
WO2016112075
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOUND FOR USE IN TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR
French Title of Invention:
COMPOSÉ POUR LE TRAITEMENT DES AFFECTIONS ASSOCIÉS À S1P1-RÉCEPTEUR
German Title of Invention:
WIRKSTOFF ZUR BEHANDLUNG VON MIT S1P1-REZEPTOR ZUSAMMENHÄNGENDEN ERKRANKUNGEN
SPC Number:

Dates

Filing date:
06/01/2016
Grant date:
16/10/2024
EP Publication Date:
15/11/2017
PCT Publication Date:
14/07/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/10/2024
EP B1 Publication Date:
16/10/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
06/01/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/10/2024
 
 

Name:
Arena Pharmaceuticals, Inc.
Address:
66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
18/10/2024
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
SHANAHAN, William R.
Address:
United States (US)

2

Name:
GLICKLICH, Alan
Address:
United States (US)

3

Name:
KAM, Maria Matilde Sanchez
Address:
United States (US)

Priority

1

Priority Number:
201562100362 P
Priority Date:
06/01/2015
Priority Country:
United States (US)

2

Priority Number:
201562159550 P
Priority Date:
11/05/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/473; A61P 37/00; A61P 29/00;

Publication

European Patent Bulletin

1

Issue number:
202442
Publication date:
16/10/2024
Description:
Grant (B1)

2

Issue number:
202452
Publication date:
25/12/2024
Description:
Document reprinted after correction (B8, B9)

Annual Fees

Annual Fee Due Date:
02/02/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
12/11/2024
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages
18/10/2024 Power Of Attorney 1
18/10/2024 Outgoing Correspondence 1